Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care >
UCLA Study Suggests Iron Is at Core of Alzheimer's Disease

Published: August 20, 2013.
By University of California - Los Angeles
http://www.newsroom.ucla.edu

Alzheimer's disease has proven to be a difficult enemy to defeat. After all, aging is the No. 1 risk factor for the disorder, and there's no stopping that. Most researchers believe the disease is caused by one of two proteins, one called tau, the other beta-amyloid. As we age, most scientists say, these proteins either disrupt signaling between neurons or simply kill them. Now, a new UCLA study suggests a third possible cause: iron accumulation.


Full Story »


More news from University of California - Los Angeles


medicine
UCLA Research Could Help Improve Bladder Function among People with Spinal Cord Injuries
People who have suffered spinal cord injuries are often susceptible to bladder infections, and those infections can cause kidney damage and even death.
medicine
UCLA Study Finds Link Between Neural Stem Cell Overgrowth And Autism-like Behavior in Mice
People with autism spectrum disorder often experience a period of accelerated brain growth after birth. No one knows why, or whether the change is linked to any specific behavioral changes. A new study by UCLA researchers demonstrates how, in pregnant mice, inflammation, a first line defense of the immune system, can trigger an excessive division of neural stem cells that can cause "overgrowth" in the offspring's brain.
medicine
UCLA Researchers Find That Drug Used for Another Disease Slows Progression of Parkinson's
A new study from UCLA found that a drug being evaluated to treat an entirely different disorder helped slow the progression of Parkinson's disease in mice. The study, published in the October edition of the journal Neurotherapeutics, found that the drug, AT2101, which has also been studied for Gaucher disease, improved motor function, stopped inflammation in the brain and reduced levels of alpha-synuclein, a protein critically involved in Parkinson's.
psychology
Soon to Become a Minority in the US, Whites Express Declining Support for Diversity
White Americans may view diversity and multiculturalism more negatively as the U.S. moves toward becoming a minority-majority nation, UCLA psychologists report.
medicine
Biochemists Solve 'Address Problem' in Cells That Leads to Lethal Kidney Disease
Research by UCLA biochemists may lead to a new treatment — or even a cure — for PH1, a rare and potentially deadly genetic kidney disease that afflicts children. Their findings also may provide important insights into treatments for Parkinson's disease, Alzheimer's disease and other degenerative diseases.
Related »

Alzheimer 
9/13/11 
Study Reveals Link Between High Cholesterol And Alzheimer's Disease
By American Academy of Neurology
ST. PAUL, Minn. – People with high cholesterol may have a higher risk of developing Alzheimer's disease, according to a study published in the September 13, 2011, issue of …
Alzheimer 
9/11/13 
Alzheimer's: Newly Identified Protein Pathology Impairs RNA Splicing
By Emory Health Sciences
Move over, plaques and tangles. Researchers at Emory University School of Medicine's Alzheimer's Disease Research Center have identified a previously unrecognized type of pathology in the brains of …
Brain 
4/21/12 
★★★ 
Alzheimer's Plaques Disrupt Brain Networks
By Washington University School of Medicine
Scientist studying the way Alzheimer's takes root in the brain have identified important new similarities between a mouse model and human Alzheimer's. …
Alzheimer 
4/15/13 
Cholesterol Increases Risk of Alzheimer's And Heart Disease
By University of Colorado Denver
AURORA, Colo. (April 15, 2013) – Researchers at the Linda Crnic Institute for Down Syndrome and the University of Colorado School of Medicine have found that a single mechanism …
Pathway 
11/20/12 
★★★ 
Discovery of Molecular Pathway of Alzheimer's Disease Reveals New Drug Targets
By Wellcome Trust
The discovery of the molecular pathway that drives the changes seen in the brains of Alzheimer's patients is reported today, revealing new targets for drug discovery that could be …
Alzheimer 
6/24/10 
Hallmark Alzheimer's Disease Changes Found in Retinas of Humans And Imaged in Live Animals
By Cedars-Sinai Medical Center
LOS ANGELES (June 24, 2010) – The nerve cell-damaging plaque that builds up in the brain with Alzheimer's disease also builds up in the retinas of the eyes – …
Alzheimer 
12/3/12 
★★★ 
Leuven Research Opens New Pathway for the Treatment of Alzheimer's Disease
By VIB (the Flanders Institute for Biotechnology)
Scientists from VIB and KU Leuven have discovered a new target molecule for the development of a treatment against Alzheimer's disease. There is currently no cure for this disease. …
Disease 
4/11/13 
New Findings on the Brain's Immune Cells During Alzheimer's Disease Progression
By Helmholtz Association of German Research Centres
The plaque deposits in the brain of Alzheimer's patients are surrounded by the brain's own immune cells, the microglia. This was already recognized by Alois Alzheimer more than one …
Vitamin 
8/18/11 
Treatment with Vitamin C Dissolves Toxic Protein Aggregates in Alzheimer's Disease
By Lund University
Researchers at Lund University have discovered a new function for vitamin C. Treatment with vitamin C can dissolve the toxic protein aggregates that build up in the brain in …
More » 
 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile  |  Japanese Edition